Amyloid-β plaques enhance Alzheimer's brain tau-seeded pathologies by facilitating neuritic plaque tau aggregation

He, Zhuohao, Guo, Jing L, McBride, Jennifer D, Narasimhan, Sneha, Kim, Hyesung, Changolkar, Lakshmi, Zhang, Bin, Gathagan, Ronald J +9 more·2018·Nature Medicine
DOI 10.1038/nm.4443

Cited by (656)

Items 401–500 of 656

  1. The Role of Thyroid Function in Alzheimer’s Disease
    Feifei Ge, Donglin Zhu, Minjie Tian, Jingping Shi · 2021 · Journal of Alzheimer s Disease
  2. An early proinflammatory transcriptional response to tau pathology is age‐specific and foreshadows reduced tau burden
    Jay Rasmussen, Adam D. Ewing, Liviu‐Gabriel Bodea, Gabriela Oana Bodea, Marla Gearing, Geoffrey J. Faulkner · 2021 · Brain Pathology
  3. Alteration of gene expression and protein solubility of the PI 5-phosphatase SHIP2 are correlated with Alzheimer’s disease pathology progression
    Kunié Ando, Fahri Küçükali, Emilie Doeraene, Siranjeevi Nagaraj, Eugenia Maria Antonelli, May Thazin Htut, Zehra Yilmaz, Andreea‐Claudia Kosa, Lidia Lopez‐Gutierrez, Carolina Quintanilla‐Sánchez et al. · 2024 · Acta Neuropathologica
  4. Transmissible long-term neuroprotective and pro-cognitive effects of 1–42 beta-amyloid with A2T icelandic mutation in an Alzheimer’s disease mouse model
    Marina Célestine, Muriel R. Jacquier‐Sarlin, Eve Borel, Fanny Petit, Fabien Lanté, Luc Bousset, Anne‐Sophie Hérard, Alain Buisson, Marc Dhénain · 2024 · Molecular Psychiatry
  5. pS396/pS404 (PHF1) tau vaccine outperforms pS199/pS202 (AT8) in rTg4510 tauopathy model
    Jonathan P. Hulse, Nicole M. Maphis, Julianne Peabody, Virginie Bondu, Bryce Chackerian, Kiran Bhaskar · 2025 · npj Vaccines
  6. Tau Liquid–Liquid Phase Separation in Alzheimer’s Disease: Mechanisms, Pathogenesis, and Therapeutic Implications
    Shijiao Tian, Yan Liu, Hu Hong, Shenghong Li · 2025 · Molecular Neurobiology
  7. The role of prion strain diversity in the development of successful therapeutic treatments
    Sara A. M. Holec, Alyssa J. Block, Jason C. Bartz · 2020 · Progress in molecular biology and translational science
  8. Traumatic brain injury alterations in the functional connectome are associated with neuroinflammation but not tau in a P30IL tauopathy mouse model
    Xuan Vinh To, Neha Soni, Rodrigo Medeiros, Khawlah Alateeq, Fatima Ali Nasrallah · 2022 · Brain Research
  9. Hydrodynamic Control of Alzheimer Aβ Fibrillation with Glucosaminic Acid Containing Click-Cyclized β-Bodies
    Yuan Zhang, Line A. Borch, Niklas Henrik Fischer, Morten Meldal · 2023 · Journal of the American Chemical Society
  10. MSUT2 regulates tau spreading via adenosinergic signaling mediated ASAP1 pathway in neurons
    Hong Wei Xu, Qi Qiu, Peng Hu, Kevt’her Hoxha, Elliot Jang, Mia O’Reilly, Christopher Kim, Zhuohao He, Nicholas P. Marotta, Lakshmi N. Changolkar et al. · 2024 · Acta Neuropathologica
  11. Strategies for measuring concentrations and forms of amyloid-β peptides
    Hangyu Shen, Keyin Liu, Fangong Kong, Mingguang Ren, Xiaoying Wang, Shoujuan Wang · 2024 · Biosensors and Bioelectronics
  12. Neuronal glutathione depletion elevates the Aβ42/Aβ40 ratio and tau aggregation in Alzheimer's disease mice
    Khairun Nisa Binti Hashim, Yukio Matsuba, Mika Takahashi, Naoko Kamano, Ikuo Tooyama, Takaomi C. Saido, Shoko Hashimoto · 2024 · FEBS Letters
  13. A natural small molecule induces MAPT clearance via mTOR-independent autophagy
    Dasol Kim, Hui‐Yun Hwang, Ho Jeong Kwon · 2021 · Biochemical and Biophysical Research Communications
  14. Learning Deficits Accompanied by Microglial Proliferation After the Long-Term Post-Injection of Alzheimer’s Disease Brain Extract in Mouse Brains
    Tetsuo Hayashi, Shotaro Shimonaka, Montasir Elahi, Shin‐ei Matsumoto, Koichi Ishiguro, Masashi Takanashi, Nobutaka Hattori, Yumiko Motoi · 2021 · Journal of Alzheimer s Disease
  15. Neuropathology of the temporal lobe
    Susana Boluda, Danielle Seilhean, Franck Bielle · 2022 · Handbook of clinical neurology
  16. Generalized Liquid Association Analysis for Multimodal Data Integration
    Lexin Li, Jing Zeng, Xin Zhang · 2022 · Journal of the American Statistical Association
  17. Induction of tauopathy in a mouse model of amyloidosis using intravenous administration of adeno‐associated virus vectors expressing human P301L tau
    Dylan J. Finneran, Taylor Desjarlais, Alayna Henry, Brianna M. Jackman, Marcia N. Gordon, David Morgan · 2024 · Alzheimer s & Dementia Translational Research & Clinical Interventions
  18. HSV-1 hijacks mitochondrial dynamics: potential molecular mechanisms linking viral infection to neurodegenerative disorders
    Siping Kuang, Zhiying He, Jingjing Zhang, Shuli Li, Juntao Ding, Zhenghai Ma, Beibei Zhang · 2025 · APOPTOSIS
  19. Total alkaloids from the seed embryo of Nelumbo nucifera Gaertn. improve cognitive impairment in APP/PS1 mice and protect Aβ-damaged PC12 cells
    Xue‐Lian Meng, Jing‐Su Xue, Shu-Jie Su, Jiang‐Min Gou, Jing Lu, Chang-Lan Chen, Chengbin Xu · 2022 · Nutritional Neuroscience
  20. Rapidly reversible persistent long-term potentiation inhibition by patient-derived brain tau and amyloid ß proteins
    T. Ondrejčák, I. Klyubin, Neng-Wei Hu, Yin Yang, Qian-Cheng Zhang, Brian J. Rodriguez, Michael J. Rowan · 2024 · Philosophical Transactions B
  21. Multimodal analysis of disease onset in Alzheimer’s disease using Connectome, Molecular, and genetics data
    Sewook Oh, Sunghun Kim, Jong‐Eun Lee, Bo‐yong Park, Ji Hye Won, Hyunjin Park · 2024 · NeuroImage Clinical
  22. Understanding the impact of amyloid beta targeted therapies on biomarkers and clinical endpoints in Alzheimer's disease
    Ronald Carl Petersen, Ana Graf, Alexandra S. Atkins, Mirosław Bryś, Jennifer Murphy, David S. Miller, Larisa Reyderman, Eric Siemers, Janice L. Smith, María C. Carrillo et al. · 2025 · Alzheimer s & Dementia Translational Research & Clinical Interventions
  23. Neurophysiological effects of human-derived pathological tau conformers in the APPKM670/671NL.PS1/L166P amyloid mouse model of Alzheimer’s disease
    Sean Tok, Hervé Maurin, C. Delay, Dries Crauwels, Nikolay V. Manyakov, Wim Van der Elst, Dieder Moechars, Wilhelmus H. I. M. Drinkenburg · 2022 · Scientific Reports
  24. A Polyaminobiaryl-Based β-secretase Modulator Alleviates Cognitive Impairments, Amyloid Load, Astrogliosis, and Neuroinflammation in APPSwe/PSEN1ΔE9 Mice Model of Amyloid Pathology
    Marie Tautou, Florian Descamps, Paul-Emmanuel Larchanché, Luc Buée, Jamal El Bakali, Patricia Melnyk, Nicolas Sergeant · 2023 · International Journal of Molecular Sciences
  25. The shape effect of reconstituted high-density lipoprotein nanocarriers on brain delivery and Aβ clearance
    Huahua Song, Xinyi Ma, Jianrong Xu, Qingxiang Song, Hu Meng, Xiao Qin Gu, Qian Zhang, Lina Hou, Lepei Chen, Yukun Huang et al. · 2018 · Nano Research
  26. Intravenous Injection of PHF-Tau Proteins From Alzheimer Brain Exacerbates Neuroinflammation, Amyloid Beta, and Tau Pathologies in 5XFAD Transgenic Mice
    Sarah Houben, Marie-Ange de Fisenne, Kunié Ando, Virginie Vanden Dries, Luc Poncelet, Zehra Yilmaz, Salwa Mansour, Robert De Decker, Jean‐Pierre Brion, Karelle Leroy · 2020 · Frontiers in Molecular Neuroscience
  27. Effects of Familial Alzheimer’s Disease Mutations on the Folding Free Energy and Dipole–Dipole Interactions of the Amyloid β-Peptide
    Darcy S. Davidson, Joshua A. Kraus, Julia M. Montgomery, Justin A. Lemkul · 2022 · The Journal of Physical Chemistry B
  28. Following the pathway to Alzheimer’s disease
    William J. Jagust · 2018 · Nature Neuroscience
  29. Hyperactive neuronal networks enhance tau spread in an Alzheimer’s disease mouse model
    Aaron J Barbour, Keegan Hoag, Eli J. Cornblath, Abigail Chavez, Alfredo Lucas, Xiaofan Li, Sydney E Zebrowitz, Chloe Hassman, Omar Vazquez, Sharon X. Xie et al. · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
  30. Lower CSF amyloid-beta1–42 predicts a higher mortality rate in frontotemporal dementia
    Vieira, Daniela, Durães, João, Baldeiras, Inês, Santiago, Beatriz, Duro, Diana, Lima, Marisa, Leitão, Maria João, Tábuas-Pereira, Miguel, Santana, Isabel · 2019 · Diagnostics
  31. Aqueous extractable nonfibrillar and sarkosyl extractable fibrillar Alzheimer’s disease tau seeds have distinct properties
    Anastasie Maté de Gérando, Anita Khasnavis, Lindsay A. Welikovitch, Harshil Bhavsar, Calina A. Glynn, Noé Quittot, Romain Perbet, Bradley T. Hyman · 2024 · Acta Neuropathologica Communications
  32. Disruption of hippocampal-prefrontal neural dynamics and risky decision-making in a mouse model of Alzheimer’s disease
    Eun Joo Kim, Sanggeon Park, Bryan P. Schuessler, Harry Boo, J. Cho, J. J. Kim · 2024 · bioRxiv
  33. Angiopoietin-2 aggravates Alzheimer’s disease by promoting blood-brain barrier dysfunction and neuroinflammation
    Eunhyeong Lee, Seoyeon Kim, Claire Zhu, Erica Acquarone, Sungsoo Kim, An Lo, Omar M. Omar, Maraake Taddese, Viviana Gradinaru, Patrick A. Murphy et al. · 2026 · Cell Reports
  34. Association of objective subtle cognitive difficulties with amyloid-β and tau deposition compared to subjective cognitive decline
    Xiaoxie Mao, Anqi Li, Ying Wang, Yan Wang, Shuhua Ren, Kun He, Yihui Guan, Qi Huang, Qihao Guo, Zijing Li et al. · 2025 · European Journal of Nuclear Medicine and Molecular Imaging
  35. Cognitive decline in community-dwelling older persons with primary age-related tauopathy: role of anatomical location of tangles and other co-existing brain pathologies
    Sonal Agrawal, Lei Yu, Lisa Laverne Barnes, David A. Bennett, Patricia A. Boyle, Julie A. Schneider · 2025 · Acta Neuropathologica
  36. Isoflurane has no effect on cognitive or behavioral performance in a mouse model of early-stage Alzheimer’s disease
    Laura Borgstedt, Sebastian Bratke, Manfred Blobner, Christoph Pötzl, Bernhard Ulm, Bettina Jungwirth, Sebastian Schmid · 2022 · Frontiers in Neuroscience
  37. Abundant copathologies of polyglucosan bodies, frontotemporal lobar degeneration with TDP‐43 inclusions and ageing‐related tau astrogliopathy in a family with a GBE1 mutation
    Maiko T. Uemura, Eun Ran Suh, John L. Robinson, Kurt R. Brunden, Murray Grossman, David John Irwin, Virginia M.‐Y. Lee, John Q. Trojanowski, Edward B. Lee, Vivianna M. Van Deerlin · 2022 · Neuropathology and Applied Neurobiology
  38. Alterations of neural activity in the prefrontal cortex associated with deficits in working memory performance
    Sihai Li, Matthew C. Rosen, Suha Chang, Samuel David, David J. Freedman · 2023 · Frontiers in Behavioral Neuroscience
  39. Molecular dynamics of amyloid-β transport in Alzheimer's disease: Exploring therapeutic plasma exchange with albumin replacement – Current insights and future perspectives
    R. Mondal, Shramana Deb, Gourav Shome, Vramanti Sarkar, Durjoy Lahiri, S.S. Datta, Julián Benito‐León · 2024 · Neurología
  40. Aβ Accumulation in Vmo Contributes to Masticatory Dysfunction in 5XFAD Mice
    H.B. Kim, D. Kim, H. Kim, W. Kim, S. Chung, S.H. Lee, Hyung‐Ryong Kim, Seog Bae Oh · 2021 · Journal of Dental Research
  41. Neurotherapy of Yi-Gan-San, a Traditional Herbal Medicine, in an Alzheimer’s Disease Model of Drosophila melanogaster by Alleviating Aβ42 Expression
    Ming‐Tsan Su, Yong-Sin Jheng, Chen‐Wen Lu, Wen-Jhen Wu, Shieh‐Yueh Yang, Wu‐Chang Chuang, Ming-Chung Lee, Chung‐Hsin Wu · 2022 · Plants
  42. Depletion of TDP-43 exacerbates tauopathy-dependent brain atrophy by sensitizing vulnerable neurons to caspase 3-mediated endoproteolysis of tau in a mouse model of Multiple Etiology Dementia
    Meghraj Singh Baghel, Grace D. Burns, Margarita Tsapatsis, Aswathy Peethambaran Mallika, Anna Lourdes Cruz, Tianyu Cao, Xiaoke K. Chen, Isabel De La Rosa, Shaelyn R Marx, Yingzhi Ye et al. · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
  43. Brain network dynamics determine tau presence while regional vulnerability governs tau load in Alzheimer’s disease
    Yu Xiao, Nicola Spotorno, Lijun An, Vincent Bazinet, Justine Y. Hansen, Olof T. Strandberg, Golia Shafiei, Hamid Behjat, Thomas Funck, Gemma Salvadó et al. · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  44. CX3CR1: a potential microglia-specific PET imaging target in Alzheimer’s and Parkinson’s diseases
    Hongzhi Yang, Yongle Wang, Yulong Xu, Changning Wang · 2025 · Frontiers in Pharmacology
  45. ApoE4 lowers the ptau217 threshold for tau aggregation and spread in an allele dose-dependent manner
    Anna Steward, Anna Dewenter, Fabian Hirsch, Sebastian Niclas Roemer, Zeyu Zhu, Amir Dehsarvi, Davina Biel, Madleen Klonowski, Lukas K. Frontzkowski, Carla Palleis et al. · 2025 · Brain
  46. In Silico Studies to Develop New GSK3β Inhibitors Effective in the Alzheimer's Disease
    Gözde Yalçın, İlkay Yıldız · 2022 · Letters in Drug Design & Discovery
  47. Computational design of a β-wrapin's N-terminal domain with canonical and non-canonical amino acid modifications mimicking curcumin's proposed inhibitory function
    Asuka A. Orr, Sarah K. Kuhlmann, Phanourios Tamamis · 2022 · Biophysical Chemistry
  48. Cross-talk between amyloid beta peptides and tau proteins in Co-aggregation investigating with the combination of coarse-grained and all-atom simulations
    Hao Shang, Mengqi Duan, Chaohong Da, Xinyi Fu, Tao Zhang · 2025 · International Journal of Biological Macromolecules
  49. Exploring Iron Deposition Patterns Using Light and Electron Microscopy in the Mouse Brain Across Aging and Alzheimer's Disease Pathology Conditions
    Victor Z. Lau, Jared VanderZwaag, Colin J. Murray, Marie‐Ève Tremblay · 2025 · Journal of Neurochemistry
  50. NADPH Oxidase Inhibition Promotes Brain Resilience by Attenuating Tauopathy and Neuroinflammation in Alzheimer's Disease
    Jihyeon Lee, Seunghwan Sim, Yinglan Jin, Hyejun Park, Eun Young Byeon, Su Jin Kim, Sujin Yun, Hye‐Eun Lee, Da Un Jeong, Jung Min Suh et al. · 2025 · Advanced Science
  51. Antibody Therapies for Alzheimer’s Disease: A New Strategy for Targeted Therapy and Blood–Brain Barrier Delivery
    Xuemei Feng, Hu Wang · 2025 · ACS Chemical Neuroscience
  52. Hypochlorous Acid-Activated UCNPs-LMB/VQIVYK Multifunctional Nanosystem for Alzheimer’s Disease Treatment
    Luying Qiao, Yang Shen, Guangzhi Li, Guanglei Lv, Chunxia Li · 2023 · Journal of Functional Biomaterials
  53. Amyloid-β and phosphorylated tau screening in bottlenose dolphin (Tursiops truncatus) and striped dolphin (Stenella coeruleoalba) brains from Italy reveals distinct immunohistochemical patterns correlating with age and co-morbidity
    Ksenia Orekhova, Camilla Testori, Federica Giorda, Carla Grattarola, Virginia Mattioda, Giovanni Di Guardo, Cristiano Corona, Massimo Castagnaro, Eva Sierra, Cristina Casalone et al. · 2024 · PLoS ONE
  54. Pharmacological Blocking of Adiponectin Receptors Induces Alzheimer’s Disease-like Neuropathology and Impairs Hippocampal Function
    Huihui Guo, Haining Ou, Jiasui Yu, Suk‐Yu Yau, Hector W. H. Tsang · 2025 · Biomedicines
  55. Poloxamer-188 Exacerbates Brain Amyloidosis, Presynaptic Dystrophies, and Pathogenic Microglial Activation in 5XFAD Mice
    Antonio Di Meco, Shahrnaz Kemal, Jelena Popović, Sidhanth Chandra, Katherine R. Sadleir, Robert J. Vassar · 2022 · Current Alzheimer Research
  56. Opinion: The Potential Role of Amyloid Beta Peptides as Biomarkers of Subconcussion and Concussion
    Angela M. Boutté, Bharani Thangavelu, John Y. Anagli · 2022 · Frontiers in Neurology
  57. Neuropathological and sociodemographic factors associated with the cortical amyloid load in aging and Alzheimer’s disease
    Sayonara Pereira da Silva, Carla Cristina Miranda Castro, Lívia Nascimento Rabelo, Rovena Clara Galvão Januário Engelberth, Bernardino Fernández‐Calvo, Felipe Porto Fiuza · 2023 · GeroScience
  58. Long noncoding RNA MEG3 activates neuronal necroptosis in Alzheimer’s disease
    Sriram Balusu, Katrien Horré, Nicola Thrupp, An Snellinx, Lutgarde Serneels, Iordana Chrysidou, Amaia M. Arranz, Annerieke S. R. Sierksma, Joel Simrén, Thomas K. Karikari et al. · 2022 · bioRxiv (Cold Spring Harbor Laboratory)
  59. Functional border-associated macrophages limit Alzheimer’s Disease progression
    Drew I. Adler, Natália Pinheiro-Rosa, Alon Millet, Zoran Z. Gajic, Evan Cheng, Begona Gamallo‐Lana, Yosuke M. Morizawa, Eric Klann, Wen‐Biao Gan, Adam C. Mar et al. · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
  60. Lipid metabolism in Alzheimer’s disease
    Jienian Zhang, Jian Sima · 2024 · Aging Research
  61. Thorase deficiency causes both Aβ accumulation and tau hyperphosphorylation in mouse brain
    Han Zhang, Menghua Cai, Fei Gao, Jia Ying Yang, Chao Li, Jingyi Han, Yue Wang, Yi Xu, Yu Hu, Hui Chen et al. · 2024 · Alzheimer s & Dementia
  62. A novel phosphodiesterase 4/5 dual-target inhibitor ameliorates neuroinflammation via the NF-κB and JNK pathway
    Liyun Zhao, Wenjie Jiang, Yingying Cao, Yi‐You Huang, Xue Wang, Li Guo, Dongke Yu, Jianyou Shi · 2025 · International Journal of Biological Macromolecules
  63. Dynein‐Dependent Endo‐Lysosomal Degradation Drives Lewy Body Disorders Accompanied by Aβ Pathology
    Linlin Zhou, Yuwei Wang, Yu Liu, Feipeng Zhu, Ge Gao, Chengjie Li, Pu Ai, Jingying Xu, J. J. Wang, Long Zhe Guo et al. · 2025 · Advanced Science
  64. Axonal tau reduction ameliorates tau and amyloid pathology in a mouse model of Alzheimer’s disease
    Abdolhossein Zare, Saeede Salehi, Jakob Maximilian Bader, Anna-Lena Wiessler, Manuela Prokesch, Vincent Albrecht, Carmen Villmann, Matthias Mann, Michael Briese, Michael Sendtner · 2025 · Translational Neurodegeneration
  65. The association of the Wnt/β-catenin signaling pathway with Alzheimer's disease
    Jiaying Ma, Yi Liu, Desheng Lu, Qi Sun · 2025 · Neuropharmacology
  66. Experimental modeling for tauopathies: An isogenic panel of humanized MAPT knock-in mice
    Takahiro Morito, Naoto Watamura · 2025 · Neuroscience Research
  67. Assessing the critical role of ceramide in the pathogenesis of Alzheimer's disease and its clinical significance
    Yi‐Wen Huang, Hua‐Chen Chan, Jing-Yi Khoo, Mei-Lin Chan, Daniel A. Bender, Vinoth Kumar Ponnusamy, Abdel Ali Belaidi, Liang‐Yin Ke · 2025 · Neurochemistry International
  68. The Determinant of Tau Spreading in Alzheimer’s Disease: Dependent on Senile Plaque, Neural Circuits, or Spatial Proximity?
    Yuichi Riku, Jean‐Pierre Brion, Kunié Ando, Toshiki Uchihara, Yasushi Iwasaki · 2025 · International Journal of Molecular Sciences
  69. CSF Aβ40 Levels Do Not Correlate with the Clinical Manifestations of Alzheimer’s Disease
    Jesús García Castro, Helena Méndez del Sol, Olaia Rodríguez Fraga, María Hernández-Barral, Soledad Serrano-López, Ana Frank García, Ángel Martín Montes · 2022 · Neurodegenerative Diseases
  70. Alzheimer’s Disease in Lebanon: Exploring Genetic and Environmental Risk Factors—A Comprehensive Review
    Mohamad Khaled, Hadi Al-Jamal, Layla Tajer, Reem El-Mir · 2024 · Journal of Alzheimer s Disease
  71. A Comparative Analysis of Two Automated Quantification Methods for Regional Cerebral Amyloid Retention: PET-Only and PET-and-MRI-Based Methods
    Sunghwan Kim, Sheng‐Min Wang, Dong Woo Kang, Yoo Hyun Um, Eun Ji Han, Sonya Youngju Park, Seunggyun Ha, Yeong Sim Choe, Hye Weon Kim, Regina E. Y. Kim et al. · 2024 · International Journal of Molecular Sciences
  72. Therapeutic impact of a benzofuran derivative on Aluminium chloride-induced Alzheimer's disease-like neurotoxicity in rats via modulating apoptotic and Insulin 1 genes
    Maha Z. Rizk, Ghadha Ibrahim Fouad, Hanan Farouk Aly, Nagy Saba El-Rigal, Kawkab A. Ahmed, Faten Fathy Mohammed, Wagdy K. B. Khalil, Somaia S. Abd El‐Karim · 2024 · Biochemical and Biophysical Research Communications
  73. A short peptide from sAPPα binding to BACE1-APP action site rescues Alzheimer-like pathology
    Xia Lai, Jie Hu, He Liu, Ling Lan, Yan Long, Xia Gao, Juan Deng · 2021 · Neuroscience Letters
  74. TAPPing into the potential of inducible tau/APP transgenic mice
    Guilian M. Xu, Brittany S. Ulm, John Clair Howard, Susan Fromholt, Qing Lü, Brian Benedict Lee, Ariel P. Walker, David Borchelt, Jada M. Lewis · 2022 · Neuropathology and Applied Neurobiology
  75. Multifactorial glial responses and their contributions to Alzheimer's disease continuum
    Masanori Hijioka, Tatsuya Manabe, Takashi Saito · 2023 · Clinical and Experimental Neuroimmunology
  76. Soluble form of the APP fragment, sAPPβ, positively regulates tau secretion
    Haruaki Sato, Kensaku Kasuga, Noriko Isoo, Toshihiro Hayashi, Takeshi Ikeuchi, Yukiko Hori, Taisuke Tomita · 2023 · Neuroscience Research
  77. Emerging Nanotechnology for the Treatment and Diagnosis of Parkinson’s Disease (PD) and Alzheimer’s Disease (AD)
    Sumasri Kotha, Manjari Sriparna, Joel Tyson, Amanda Li, Weiwei He, Xiaobo Mao · 2024 · Stem cell biology and regenerative medicine
  78. Ocular Exploration in the Diagnosis and Follow-Up of the Alzheimer’s Dementia
    Instituto de Investigaciones Oftalmológicas Ramón Castroviejo, Universidad Complutense de Madrid, Madrid, Spain, Elena Salobrar‐García, Rosa de Hoz, Instituto de Investigaciones Oftalmológicas Ramón Castroviejo, Universidad Complutense de Madrid, Madrid, Spain, Facultad de Óptica y Optometría, Universidad Complutense de Madrid, Madrid, Spain, Ana Isabel Ramirez, Instituto de Investigaciones Oftalmológicas Ramón Castroviejo, Universidad Complutense de Madrid, Madrid, Spain, Facultad de Óptica y Optometría, Universidad Complutense de Madrid, Madrid, Spain, Juan Jose Salazar, Instituto de Investigaciones Oftalmológicas Ramón Castroviejo, Universidad Complutense de Madrid, Madrid, Spain et al. · 2019 · Codon Publications eBooks
  79. Different Morphology of Neuritic Plaques in the Archicortex of Alzheimer’s Disease with Comorbid Synucleinopathy: A Pilot Study
    Nikol Jankovská, Tomáš Olejár, Jaromír Kukal, Radoslav Matěj · 2021 · Current Alzheimer Research
  80. Pathological changes induced by Alzheimer’s brain inoculation in amyloid-beta plaque-bearing mice
    Suzanne Lam, Anne‐Sophie Hérard, Susana Boluda, Fanny Petit, Sabiha Eddarkaoui, Karine Cambon, The Brainbank Neuro-CEB Neuropathology Network, Jean‐Luc Picq, Luc Buée, Charles J. Duyckaerts et al. · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  81. Synergistic associations of amyloid-β and phosphorylated tau with tau aggregation and cognitive decline in Alzheimer's disease
    Chunhua Zhang, Yaojun Tai, Min Kong, Pengyuan Jia, Guozhao Ma, Maowen Ba, Alzheimer’s Disease Neuroimaging Initiative · 2025 · Journal of Alzheimer s Disease
  82. Human and Mouse Alzheimer's Seeds Differentially Affect Amyloid Deposition and Microglia‐Dependent Plaque Response in Aged Mice
    Juana Andreo‐Lopez, Cristina Nuñez‐Diaz, Kelly Do Huynh, Marie Minh Thu Nguyen, Celia Da Cunha, Francisco Cantero‐Molina, Cynthia Campos‐Moreno, Stefania Zimbone, Francesco Bellia, Maria Laura Giuffrida et al. · 2025 · Aging Cell
  83. Patterns of pathological tau deposition reflect the dynamics of cortical brain activity
    Feng Han, Xi Chen, Alice Murphy, JiaQie Lee, Jacob Ziontz, Susan M. Landau, Suzanne L. Baker, Theresa M. Harrison, William J. Jagust · 2025 · Cell Reports
  84. Tau seeding activity in the cerebrospinal fluid of Alzheimer disease patients predicts short-term cognitive decline
    Ludivine Houzé, Marc Dhénain, Suzanne Lam, Fanny Petit, Stéphane Haı̈k, François Mouton‐Liger, Jacques Hugon, Julie Dam, Claire Paquet, Ralf Jockers et al. · 2025 · Alzheimer s Research & Therapy
  85. Activation of PPARα by gemfibrozil lowers tau-associated neuropathology in the MAPT mouse model of Alzheimer’s disease
    Moumita Majumder, Debashis Dutta, Ramesh Kumar Paidi, Kalipada Pahan · 2025 · Brain Research
  86. IL-27, a metabolic regulator secreted by astrocytes in response to GLP-1RA OHP2, modulates microglial reprogramming in Alzheimer’s disease by regulating cGAS lactylation
    Yixuan Du, Lingxi Wu, Yang Mao, Song Chen, Xiangdong Gao · 2026 · Journal of Neuroinflammation
  87. Type-1 interferons associated with microglial-mediated neuroinflammation in Alzheimer’s disease
    Daniel C. Shippy, Michael L. Sande, Tyler Kent Ulland · 2026 · Journal of Neuroinflammation
  88. Pathological Roles of INPP5D in Alzheimer’s Disease
    Yung Ning Chu, Aika Akahori, Sho Takatori, Taisuke Tomita · 2023 · Advances in experimental medicine and biology
  89. Molecular dynamics of amyloid-β transport in Alzheimer's disease: Exploring therapeutic plasma exchange with albumin replacement – Current insights and future perspectives
    R. Mondal, Shramana Deb, Gourav Shome, Vramanti Sarkar, Durjoy Lahiri, S.S. Datta, Julián Benito‐León · 2025 · Neurología (English Edition)
  90. Amyloid fishing: β-Amyloid adsorption using tailor-made coated titania nanoparticles
    Elad Arad, Raz Jelinek, Hanna Rapaport · 2022 · Colloids and Surfaces B Biointerfaces
  91. Does proteopathic tau propagate trans-synaptically in the brain?
    Wen Hui Hu, Fei Liu, Cheng‐Xin Gong, Khalid Iqbal · 2022 · Molecular Neurodegeneration
  92. Novel social stimulation ameliorates memory deficit in Alzheimer's disease model through activating α-secretase
    Qiaoyun Ren, Susu Wang, Junru Li, Kun Cao, Mei Zhuang, Miao Wu, Junhua Geng, Zhengping Jia, Wei Xie, An Liu · 2024 · Journal of Neuroscience
  93. Generation of Alzheimer’s Disease Model Derived from Induced Pluripotent Stem Cells with APP Gene Mutation
    Yena Kim, Binna Yun, Byoung Seok Ye, Bo Young Kim · 2024 · Biomedicines
  94. Multimodal Blood-Based Biomarker Panel Reveals Altered Lysosomal Ionic Content in Alzheimer’s Disease
    Senthilkumar Deivasigamani, Shareefa Thekkan, Hernando Martínez Vergara, Owen M. Connolly, Mali L. Cosden, Thienlong Phan, Sean Smith, Jacob Marcus, Jason M. Uslaner, Dhivya Venkat et al. · 2024 · ACS Chemical Biology
  95. Molecular basis of cross-interactions between Aβ and Tau protofibrils probed by molecular simulations
    Fufeng Liu, Luying Jiang, Jingcheng Sang, Fuping Lu, Li Li · 2022 · Chinese Journal of Chemical Engineering
  96. Tau Pathology in Neurodegenerative Diseases
    Thomas Vogels, Tomáš Hromádka · 2021 · Neuromethods
  97. Pre-therapeutic Microglia Activation and Sex Determine Therapy Effects of Chronic Immunomodulation
    Gloria Biechele, Tanja Blume, Maximilian Deußing, Benedikt Zott, Yuan Shi, Xianyuan Xiang, Nicolai Franzmeier, Gernot Kleinberger, Finn Peters, Katharina Ochs et al. · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  98. Astrocyte-secreted glypican-4 drives APOE4-dependent tau pathology
    Sivaprakasam R. Saroja, Kirill Gorbachev, Julia TCW, Alison Goate, Ana C. Pereira · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  99. Enhanced microglial dynamics and paucity of tau seeding in the amyloid plaque microenvironment contributes to cognitive resilience in Alzheimer’s disease
    Nur Jury, Yanwen You, Pablo Martínez, Javier Redding‐Ochoa, Hande Karahan, Travis S. Johnson, Jie Zhang, Jungsu Kim, Juan Carlos Troncoso, Cristian A. Lasagna‐Reeves · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
  100. Single-Domain Antibody-Based Protein Degrader for Synucleinopathies
    Yixiang Jiang, Yan Lin, Amber M. Tetlow, Ruimin Pan, Changyi Ji, Xiang‐Peng Kong, Erin E. Congdon, Einar M. Sigurdsson · 2024 · bioRxiv (Cold Spring Harbor Laboratory)